Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.01 per share
-
Shares outstanding
-
78,459,900
-
Total 13F shares
-
56,282,420
-
Share change
-
+3,832,410
-
Total reported value
-
$7,602,972,962
-
Put/Call ratio
-
65%
-
Price per share
-
$134.86
-
Number of holders
-
242
-
Value change
-
+$629,022,955
-
Number of buys
-
168
-
Number of sells
-
74
Institutional Holders of Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX) as of Q4 2025
As of 31 Dec 2025,
Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX) was held by
242 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,282,420 shares.
The largest 10 holders included
TCG Crossover Management, LLC, UBS Group AG, Darwin Global Management, Ltd., MORGAN STANLEY, Point72 Asset Management, L.P., Vestal Point Capital, LP, Caligan Partners LP, Paradigm Biocapital Advisors LP, FMR LLC, and Cormorant Asset Management, LP.
This page lists
242
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.